Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,747 | 416 | 94.9% |
| Education | $360.80 | 8 | 5.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $1,119 | 80 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $872.79 | 38 | $0 (2024) |
| C. R. Bard, Inc. & Subsidiaries | $736.46 | 25 | $0 (2024) |
| Janssen Biotech, Inc. | $476.39 | 36 | $0 (2024) |
| Rochester Medical Corporation | $431.98 | 24 | $0 (2022) |
| ABBVIE INC. | $335.36 | 29 | $0 (2024) |
| PFIZER INC. | $320.53 | 49 | $0 (2023) |
| Blue Earth Diagnostics Limited | $283.73 | 10 | $0 (2024) |
| Teleflex LLC | $213.14 | 10 | $0 (2024) |
| Myovant Sciences Inc. | $212.96 | 14 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $810.64 | 39 | Dendreon Pharmaceuticals LLC ($185.83) |
| 2023 | $1,468 | 60 | C. R. Bard, Inc. & Subsidiaries ($605.62) |
| 2022 | $1,112 | 67 | Rochester Medical Corporation ($246.30) |
| 2021 | $576.28 | 38 | Astellas Pharma US Inc ($128.16) |
| 2020 | $596.84 | 30 | Astellas Pharma US Inc ($348.45) |
| 2019 | $643.95 | 52 | Dendreon Pharmaceuticals LLC ($138.71) |
| 2018 | $1,063 | 64 | Dendreon Pharmaceuticals LLC ($347.33) |
| 2017 | $837.08 | 74 | Astellas Pharma US Inc ($194.62) |
All Payment Transactions
424 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $14.30 | General |
| Category: ONCOLOGY | ||||||
| 12/16/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 12/03/2024 | C. R. Bard, Inc. & Subsidiaries | Personal Catheter Intermittent Catheter (Device) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: Urology | ||||||
| 11/26/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: Oncology | ||||||
| 11/18/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 11/06/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: UROLOGY | ||||||
| 10/31/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $29.87 | General |
| Category: Diagnostic Imaging | ||||||
| 10/22/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 10/18/2024 | ABC Home Medical Supply, Inc. | — | Food and Beverage | In-kind items and services | $31.65 | General |
| 10/02/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: UROLOGY | ||||||
| 10/01/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 09/17/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $33.07 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 09/11/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 09/05/2024 | ABC Home Medical Supply, Inc. | — | Food and Beverage | In-kind items and services | $29.63 | General |
| 09/03/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: Diagnostic Imaging | ||||||
| 08/20/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: Oncology | ||||||
| 08/14/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 08/06/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 07/29/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: Oncology | ||||||
| 07/23/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 07/16/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: Diagnostic Imaging | ||||||
| 07/15/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 07/11/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: Oncology | ||||||
| 07/01/2024 | C. R. Bard, Inc. & Subsidiaries | Bard Urinary Drainage Bag (Device) | Food and Beverage | In-kind items and services | $38.81 | General |
| Category: Urology | ||||||
| 06/19/2024 | COLOPLAST CORP | SpeediCath (Device) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: Continence Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,623 | 2,251 | $507,046 | $149,633 |
| 2022 | 19 | 1,760 | 2,422 | $529,150 | $155,762 |
| 2021 | 27 | 1,987 | 2,796 | $928,691 | $187,185 |
| 2020 | 22 | 1,885 | 2,538 | $633,662 | $178,090 |
All Medicare Procedures & Services
89 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 529 | 726 | $151,008 | $62,326 | 41.3% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 19 | 176 | $104,896 | $23,697 | 22.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 164 | 180 | $36,900 | $15,865 | 43.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 92 | 92 | $29,440 | $10,480 | 35.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 92 | 157 | $22,294 | $9,085 | 40.8% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 18 | 19 | $19,247 | $5,582 | 29.0% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 90 | 99 | $52,436 | $4,936 | 9.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 85 | 91 | $12,831 | $4,894 | 38.1% |
| 52287 | Exam with injections of chemical for destruction of bladder using an endoscope | Facility | 2023 | 20 | 25 | $21,050 | $3,138 | 14.9% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 14 | 14 | $15,638 | $1,478 | 9.5% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Facility | 2023 | 16 | 16 | $4,064 | $1,270 | 31.2% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 11 | 75 | $2,850 | $1,205 | 42.3% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 19 | 44 | $2,684 | $1,100 | 41.0% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 13 | 13 | $7,631 | $1,090 | 14.3% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 114 | 143 | $6,006 | $1,010 | 16.8% |
| 81002 | Urinalysis, manual test | Office | 2023 | 215 | 262 | $1,572 | $876.92 | 55.8% |
| 51701 | Insertion of temporary bladder tube | Office | 2023 | 15 | 17 | $2,142 | $572.39 | 26.7% |
| 51700 | Simple bladder irrigation and/or instillation | Facility | 2023 | 37 | 42 | $7,993 | $442.32 | 5.5% |
| 76872 | Ultrasound scan of pelvic region through rectum | Facility | 2023 | 11 | 11 | $737.00 | $271.92 | 36.9% |
| 51784 | Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | Facility | 2023 | 15 | 15 | $2,805 | $213.30 | 7.6% |
| 51741 | Electronic assessment of bladder emptying | Facility | 2023 | 34 | 34 | $2,822 | $99.04 | 3.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 460 | 629 | $130,832 | $52,551 | 40.2% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 19 | 188 | $112,048 | $25,915 | 23.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 237 | 270 | $38,070 | $16,462 | 43.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 181 | 200 | $41,000 | $15,325 | 37.4% |
About Dr. Peter Zografides, MD
Dr. Peter Zografides, MD is a Urology healthcare provider based in Toledo, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1467453811.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Peter Zografides, MD has received a total of $7,108 in payments from pharmaceutical and medical device companies, with $810.64 received in 2024. These payments were reported across 424 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($6,747).
As a Medicare-enrolled provider, Zografides has provided services to 7,255 Medicare beneficiaries, totaling 10,007 services with total Medicare billing of $670,670. Data is available for 4 years (2020–2023), covering 89 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Toledo, OH
- Active Since 08/09/2005
- Last Updated 12/01/2009
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1467453811
Products in Payments
- PROVENGE (Drug) $872.79
- Bard Urinary Drainage Bag (Device) $644.43
- XTANDI (Drug) $592.20
- ORGOVYX (Drug) $266.37
- Myrbetriq (Drug) $259.04
- ZYTIGA (Drug) $215.75
- ERLEADA (Drug) $209.72
- POSLUMA (Drug) $191.90
- TOVIAZ (Drug) $176.98
- ELIGARD (Drug) $173.25
- Xtandi (Drug) $170.39
- XIAFLEX (Biological) $164.78
- PYLARIFY (Drug) $159.95
- Androgel (Drug) $155.64
- Erleada (Drug) $138.92
- XYOSTED (Drug) $128.53
- TRDE UP PROMO,KS TO SPIES FLEXC,US DEF (Device) $126.15
- Nubeqa (Drug) $123.84
- UROLIFT (Device) $122.15
- BOTOX (Biological) $118.74
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Toledo
Dr. Salvador Peron, M.d, M.D
Urology — Payments: $19,792
Dr. Saleem Zafar, M.d, M.D
Urology — Payments: $12,409
Firas Petros, M.d, M.D
Urology — Payments: $12,016
Dr. Steven Ariss, Md, MD
Urology — Payments: $8,924
Dr. Carin Hopps, M.d, M.D
Urology — Payments: $8,723
Philip Wong, Md, MD
Urology — Payments: $8,545